Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026

This cycle was dominated by a single large Cambridge study linking recreational drug use, including cannabis, to significantly elevated stroke risk, especially in younger populations. Alongside that clinical signal, a wave of DEA scheduling actions targeting novel synthetic opioids rounded out a regulatory-heavy news period.

The Cambridge stroke data deserves a permanent place in every clinician’s cannabis counseling toolkit, particularly for younger patients who assume plant-based means risk-free. Screen broadly, counsel specifically, and remember that good medicine means weighing cardiovascular signals just as seriously as we weigh the benefits.